Published in the Orthodaepic Journal of Sports Medicine in July 2022, this study examined the effectiveness of CBD for post-operative arthroscopic rotator cuff repair surgery.
This was an FDA sanctioned, multi-center, placebo-controlled, randomized, double-blinded trial conducted in patients undergoing arthroscopic rotator cuff repair (ARCR). The goal was to determine if CBD helped improve immediate post-operative pain and overall patient satisfaction.
A total of 80 patients participated in the study. The experimental group was given Oravexx, a CBD-based oromucosal (tincture in the cheek) product with 25mg CBD for body weights less than 176 lbs. (80kg) and 50 mg CBD for body weights above 176 lbs. Patients used the product for 14 days immediately following the surgery.
The authors findings in their words:
- "On Day 1, VAS pain score was significantly lower in those receiving CBD"
- "patients receiving 50 mg of CBD reported lower VAS [pain] scores at day 1 and higher satisfaction with pain control at day 1 and 2 compared to those receiving 25 mg of CBD and control group respectively."
- "On Day 7 and Day 14, there were no statistically significant differences in VAS [pain] score, opioid consumption, or patient satisfaction with pain control"
The results indicate that CBD can be an effective pain treatment immediately following arthroscopic rotator cuff repair surgery, but it's not as effective after the first few days.
The abstract is here at Sagepub.com.